Clinical Trial Update: Oral Valganciclovir Versus Valacyclovir [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing oral valganciclovir versus valacyclovir in patients with chronic lymphocytic leukemia and leukemia, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Leukemia

Drugs mentioned

• Valacyclovir (Valacyclovir)
• Valganciclovir (Valganciclovir)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Leukemia | Phase 2 | Status: COMPLETED